PS-07-015 Soft-silicone Penile Prosthesis Implant in the Management of Delayed or Refractory Ischemic Priapism

Vagnoni, Valerio; Franceschelli, Alessandro; Gentile, Giorgio; Masetti, M.; Fiorillo, Alessandro; Colombo, F.

doi:10.1016/j.jsxm.2019.03.103

Cited by 1 publication

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most of the patients had a MPP implant either early or delayed after the priapism episode, Figure 3 shows the relation between the number of IPP and MPP in the different papers. Only two studies used a higher number of IPP compared to MPP—Uberoi et al of a series of eight patients, seven had a three-piece IPP implant, and only one had an MPP ( 8 , 14 - 16 , 21 , 22 ) and Sedigh et al had only one MPP implant vs. four IPP ( 23 ). Zacharakis et al [2015] describe a series of 10 patients with early MPP implant after priapism with later exchange to IPP ( 16 ).…”

Section: Resultsmentioning

confidence: 99%

“…The majority of studies examining the occurrence of penile shortening after priapism have not found evidence to support this phenomenon ( 15 , 17 , 19 , 22 , 23 ). However, Zacharakis [2014] reported this complication in his series, and it was observed more frequently in patients who underwent DP implants compared to those who received early implants (40% vs. 3%, P<0.001) ( 10 ).…”

Section: Resultsmentioning

confidence: 99%

“…The most frequently reported complications following PP procedures include infection (range, 6–50%), erosion (range, 1–9%), curvature (range, 1–10%), and mechanical issues with the device, such as malfunction or auto-inflation (range, 2–5%) ( 8 - 11 , 14 - 16 , 19 , 24 , 27 ). Sedigh [2011] and Vagnoni [2019] found that all patients initially experienced a decrease in penile sensitivity, but this was a temporary side effect ( 22 , 23 ).…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Penile prosthesis in priapism: a systematic review of outcomes and complications

Velasquez,

Guimaraes,

Lescay

et al. 2024

Transl Androl Urol

View full text Add to dashboard Cite

Background Priapism is a rare condition characterized by persistent erection of the penis that lasts more than 4 hours in the absence of sexual stimulation and is associated with significant morbidity and complications, including erectile dysfunction and penile fibrosis. Surgical management of priapism can be extremely challenging. We herein provide a comprehensive review that aims to evaluate the role of penile prosthesis (PP) implantation in the management of priapism. Methods A systematic literature search was performed using the following databases: PubMed, Embase, and Scopus to identify studies that evaluated the effectiveness of PP implantation in treating priapism and the long-term complications, outcomes, and patients’ satisfaction rate. Results Out of 717 English-language studies published between 2002 and 2022, 17 were chosen for this review. Majority of patients had a malleable PP (MPP) implant, either early or delayed after the priapism episode. Early placement (EP) of PP is widely defined between studies ranging from less than 72 hours, within 1 week, and within 3 weeks. Most common causes of priapism were sickle cell anemia (SCA), medication-induced, and idiopathic. Studies show a higher satisfaction rate ranging between 80% and 100%, with sexual intercourse achievement ranging between 64.2% and 100%. Based on the GRADE system, included studies rated as very low quality of evidence. Commonly reported complications that arise after PP procedures, include device infection, erosion, curvature, and mechanical malfunction, such as auto-inflation. Conclusions PP can be an effective treatment option for priapism, particularly in cases of ischemic priapism lasting more than 36 hours or recurrent priapism that is medically refractory. However, due to the very low quality of evidence, larger, well-designed studies are warranted where long-term outcomes, patients’ satisfaction, and complications following priapism-related PP implantation are measured as endpoints.

show abstract